Celltrion Pharm, Inc. (KOSDAQ:068760)
40,900
-600 (-1.45%)
Nov 20, 2026, 1:23 PM KST
| Market Cap | 1.81T -32.5% |
| Revenue (ttm) | 274.73B +53.2% |
| Net Income | 26.03B +146.8% |
| EPS | 583.36 +146.0% |
| Shares Out | 44.21M |
| PE Ratio | 70.11 |
| Forward PE | n/a |
| Dividend | 196.08 (0.48%) |
| Ex-Dividend Date | Dec 29, 2026 |
| Volume | 26,214 |
| Open | 41,150 |
| Previous Close | 41,500 |
| Day's Range | 40,500 - 41,250 |
| 52-Week Range | 35,600 - 78,300 |
| Beta | 0.91 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |